Navigation Links
Blood Pressure Control in Middle Age Can Lower Lifetime Heart Risk
Date:12/19/2011

MONDAY, Dec. 19 (HealthDay News) -- Blood pressure changes in middle age can affect your lifetime risk for heart disease and stroke, a new study suggests.

U.S. researchers analyzed data from almost 62,000 people whose blood pressure readings were tracked for an average of 14 years.

People who kept or lowered their blood pressure to normal levels by age 55 had the lowest lifetime risk (22 percent to 41 percent) for heart disease. The risk for people who had high blood pressure at age 55, however, was 42 percent to 69 percent.

When all blood pressure levels were factored in, the overall lifetime heart disease risk for people over the age of 55 was about 53 percent for men and about 40 percent for women.

"This study adds to our existing knowledge that hypertension is the most important modifiable risk factor for cardiovascular disease, including coronary heart disease and stroke," said expert Dr. Robert Graham, an internist at Lenox Hill Hospital in New York City. "Unfortunately, many patients do not take this 'silent disease' seriously because they usually don't see or feel the effects of their hypertension until some catastrophic outcome has occurred," he added.

Among the other findings:

  • Women generally had higher increases in middle age than men, and women who have high blood pressure by early middle age (average age 41) have a higher lifetime risk for heart disease (49 percent) than those who have maintained normal blood pressure up to age 55.
  • At an average age of 55, 26 percent of men had normal blood pressure, as did 41 percent of women, while about 49 percent of men and 48 percent of women had prehypertension.
  • Nearly 70 percent of men who develop high blood pressure in middle age will experience a cardiovascular event such as a stroke or heart attack by age 85, the team found.

The study appears Dec. 19 in the journal Circulation.

"Taking blood pressure changes into account can provide more accurate estimates for lifetime risk of cardiovascular disease, and it can help us predict individualized risk, and thus, individualized prevention strategies," study author Norrina Allen, an assistant professor in the department of preventive medicine at the Northwestern University Feinberg School of Medicine, in Chicago, explained in a journal news release.

"Both avoiding hypertension during middle age or delaying the onset of the development of hypertension appear to have a significant impact on an individual's remaining lifetime risk for CVD," Allen noted.

Graham agreed. He said that hypertension in middle age "can affect one's lifetime risk for heart disease and stroke. Fortunately, with medications and lifestyle changes, patients who control their blood pressure during middle age had the lowest lifetime risk of cardiovascular disease, while those with an increase in blood pressure had the highest risk."

More information

The U.S. National Heart, Lung, and Blood Institute offers a guide to lowering high blood pressure.

-- Robert Preidt

SOURCE: Robert Graham, M.D., internist, Lenox Hill Hospital, New York City; Circulation, news release, Dec. 15, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Brief, Intense Exercise Lowers Blood Sugar, Small Study Finds
2. Less blood needed post-surgery, says NEJM study
3. Team designs a bandage that spurs, guides blood vessel growth
4. Blood test might predict how well a depressed patient responds to antidepressants
5. Low Iron Levels May Increase Blood Clot Risk
6. Key genetic error found in family of blood cancers
7. University of Maryland finds restricting post-surgery blood transfusion is safe for some hip patients
8. Study Finds Fewer Blood Transfusions Needed After Hip Surgeries
9. Cancer Outpatients at Greater Risk for Blood Clots
10. Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient
11. Massive DNA search uncovers new mutations driving blood cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Control in Middle Age Can Lower Lifetime Heart Risk
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: